Background: Tubercular empyema is one of the commonest chronic diseases in the developing countries of the world including India. As the problem of drug resistant strain of tubercular bacilli is increasing, new modalities of treatment that could act against resistant strain are needed.
INTRODUCTION
Tuberculous empyema presents a more diffi cult problem, since the lung and pleura are usually involved with irreversible pathological changes which make expansion and proper functioning of the lung impossible. However, it appeared theoretically possible that if tuberculous empyema were treated at an early stage, before irreversible changes took place that a cure might be obtained.
This report deals with the successful treatment of a patient with tuberculous empyema by use of low level laser therapy.
CASE REPORT
A 19-year-old male, was admitted on February 2008 with two weeks history of high grade fever, dry cough and left sided chest pain. Patient had been treated for sputum positive pulmonary tuberculosis from April 2007 to October 2007. History of contact with known tuberculous patient was positive. He had received Isoniazid (INH) 600 mg, Rifampicin (RIF) 600mg, Ethambutol (EMB) 1200 mg, Pyrazinamide (PZA) 1500 mg Directly Observed Treatment, Short course (DOTS Category-I).
On general examination, he was cachectic, febrile, trachea shifted towards right side. Systemic examination revealed dull percussion on left side of chest. Auscultation of chest revealed breath sound absent in left chest.
A full blood examination showed Haemoglobin of 11.6gm%, white cell count 12,700, Erythrocytes Sedimentation Rate of 30mm at the end of 1 st hour. Blood sugar, urea, creatinine were normal. Human Immunodefi ciency Virus, T-cell interferons were negative and Tubercular antibody were positive. Thick pus from pleural cavity showed acid-fast bacilli (AFB) in Ziehl Neelsen (ZN) staining. Culture on Lowen stein -Jensen slopes(L-J) was negative but Deoxyribo Nucleic Acid testing for Mycobacterium tuberculosis amplifi ed using the polymerase chain reaction (PCR) was positive. Sputum for acid-fast bacilli was negative on ZN staining. Culture of sputum on L-J slopes was negative. Culture for pyogenic organisms was negative. X-ray of chest revealed homogenous opacity left side of chest with shifting of the mediastinum towards right side ( Figure-1 ).
After confi rmation of the diagnosis, patient was put on DOTS category -II along with repeated aspiration because patient was not ready for intercostal tube drainage. In spite of this treatment for 2 months, amount of pleural fl uid was increasing radiologically and patient deteriorated clinically.
The study has been approved by institutional review board. After obtaining the informed consent, we gave intrapleural laser therapy along with continuation of DOTS category-II. The intrapleural laser therapy required local anesthesia. The nitrogen laser used in this study (wave length 337 nm, energy 300 microjoules and an average power output of 5 mW at the tip of the fi ber) was manufactured by Raja Ramanna Center for Advanced Technology , Indore, India.
The empyema was exposed to nitrogen laser irradiation for 780 seconds at 72 hours interval for total 20 sitting. For laser irradiation the sterilized jalco canula (16 Gauge, 50 mm length) was introduced inside the pleural cavity and after aspiration of fl uid from pleural cavity, the optical fi ber of the laser equipment was introduced into the pleural cavity. At each session whole of the plural cavity was irradiated.
After the fi fth laser irradiation session, decrease in chest pain was reported and pleural fl uid aspiration became pus mixed with blood. After the tenth laser irradiation session, serous pleural fl uid aspirated. After 20 sessions of laser irradiation the empyema was healed completely, PCR for M.TB complex negative and the patient also regained almost complete expansion of lung. Follow-up x-rays of chest revealed resolution of empyema on left side of chest and complete expansion of left lung ( Figure-2 and 3 ).
Patient develops left sided mild pneumothorax after two months of stopping treatment which was managed conservatively. There was no recurrence of disease during 2 years of follow up.
DISCUSSION
This study was motivated by the encouraging results obtained earlier by us on the use of low level nitrogen laser therapy in chronic pulmonary tuberculosis non-responding tubercular lymphadenopathy and sinus. 1, 2, 3 Results of the case study showed that patient who had received antitubercular treatment 2 months and had been aspirated showing no response to the therapy responded to intrapleural nitrogen laser irradiation. The exact mechanism of therapy by nitrogen laser irradiation is not clearly understood. The high intensity focused nitrogen laser irradiation has been shown to lead to direct inhibition of bacteria. 4 Even low intensity nitrogen laser irradiation has been shown to result in signifi cant changes in fl uidity of lipid regions in cell wall of laser-exposed cells which could affect infectivity of mycobacterium tuberculosis in the host. 5 Experiments also suggest that nitrogen laser irradiation can infl uence the immune response. For example nitrogen laser irradiation was observed to enhance the intracellular killing of internalized bacteria in human neutrophils. 6 However; more work is required for a more clear understanding of the mechanisms involved in the observed therapeutic effect of nitrogen laser irradiation.
SUMMARY
A patient with tuberculous empyema and nonexpandable lung was treated by the intra pleural low level laser therapy. LLLT resulted in prompt expansion of the lung and disappearance of the empyema. The LLLT may be specifi c in the treatment of tuberculous empyema when used before irreversible pathological changes have taken place.
CONCLUSION
Nitrogen laser irradiation was observed to result in the healing of the tubercular empyema which was not responding to conventional antitubercular and pus aspiration. The laser irradiation was also found to make the fl uid free of mycobacterium tuberculosis. Further randomized studies with more patients are therefore, desirable to establish this mode of therapy for the treatment of tubercular empyema.
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